Anxiolytic Activity of Atrial Natriuretic Peptide in Patients With Panic Disorder
Authors:
- Andreas StröhleASAndreas Ströhle
- Michael KellnerMKMichael Kellner
- Florian HolsboerFHFlorian Holsboer
- Klaus WiedemannKWKlaus Wiedemann
- 1 September 2001
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 158 (9) , 1514-1516
Abstract
Preclinical evidence exists for the anxiolytic activity of atrial natriuretic peptide, which is released during lactate-induced panic attacks. Atrial natriuretic peptide receptor modulation may have antipanic activity in patients with panic disorder. The effects of 150 microg of atrial natriuretic peptide and placebo on panic attacks induced by cholecystokinin tetrapeptide (CCK-4) (25 microg) were studied in 10 panic disorder patients. The panicogenic activity of CCK-4 was measured with the Acute Panic Inventory. Panic attacks occurred in seven patients in the placebo condition and in two patients in the atrial natriuretic peptide condition. CCK-4 administration was accompanied by a significant increase in Acute Panic Inventory scores. Pretreatment with atrial natriuretic peptide resulted in significantly lower Acute Panic Inventory scores than pretreatment with placebo. The results support the antipanic activity of atrial natriuretic peptide. Nonpeptidergic atrial natriuretic peptide receptor ligands may be ultimately used to treat anxiety disorders.Keywords
This publication has 9 references indexed in Scilit:
- Increased ACTH Concentrations Associated with Cholecystokinin Tetrapeptide-Induced Panic Attacks in Patients with Panic DisorderNeuropsychopharmacology, 2000
- Central and Peripheral Administration of Atriopeptin Is Anxiolytic in RatsNeuroendocrinology, 1997
- Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panicAmerican Journal of Psychiatry, 1995
- Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patientsAmerican Journal of Psychiatry, 1994
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- On the blood-brain barrier to peptides: specific binding of atrial natriuretic peptide in vivo and in vitroBrain Research, 1991
- Comparison of the panicogenic effect of cholecystokinin 30–33 and carbon dioxide in panic disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1991
- Measurement of lactate-induced panic and anxietyPsychiatry Research, 1987
- Atrial Natriuretic Factor: A Hormone Produced by the HeartScience, 1985